Research into new test methods to measure pain with two existing drugs (nefopam and oxycodone)
This study is exploring fresh ways to understand and measure chronic (long-term) pain. They want to see if new measuring tools are effective when people take two pain relief medicines already in use: nefopam and oxycodone. Nefopam is a non-opioid painkiller, while oxycodone is a stronger opioid painkiller. This type of study, called a 'Human Pharmacology (Phase I)' study, is an early stage of research. It's about figuring out how new ways of measuring pain behave in people, rather than primarily testing if a new drug works. Participants will be adults with pain. The aim is to improve how we assess pain, which could eventually lead to better treatments.
At a glance
What is this study about?
Imagine trying to explain how much your pain hurts to someone else. It's tricky, isn't it? Well, doctors and researchers face a similar problem. They need better ways to understand and measure a person's pain to make sure they're getting the right treatment. This study is all about finding new and improved methods to do just that.
They're not testing new medicines in this particular study. Instead, they're using two pain relief medications that are already available and prescribed: nefopam and oxycodone. Nefopam is a painkiller that works differently from common ones like paracetamol or ibuprofen, and it's not an opioid. Oxycodone is a stronger, opioid-based painkiller often used for more severe pain. By giving these known drugs and then using the new measuring tools, the researchers can see how well these tools pick up changes in pain levels.
This kind of research is known as 'Phase I' or 'Human Pharmacology'. It's usually one of the very first steps when new medical ideas are tested in people. It's not primarily focused on whether a drug works for a disease, but rather on understanding how drugs or new methods behave in the human body. In this case, it's about understanding how the new pain measurement techniques work. The insights gained here could pave the way for more accurate pain assessments in the future, ultimately helping doctors choose the best treatments for people living with ongoing pain.
Key takeaways
- Study aims to find better ways to measure long-term pain.
- Uses two existing pain medications: nefopam and oxycodone.
- It's an early-stage research study (Phase I).
- Open to adults aged 18 and over, both men and women.
- Participation helps future pain treatment and assessment.
- You can withdraw from the study at any time.
Who may be eligible?
To join this study, you need to be an adult, aged 18 or older. There is no upper age limit, meaning older adults can also take part. The study is open to both men and women.
Because this study is about measuring pain, it's likely they will be looking for people who experience ongoing, long-term pain. However, the details of what type of pain or other health conditions might make you suitable aren't fully explained here. Your doctor or the study team will be able to tell you if your specific health situation matches what they are looking for.
Generally, clinical studies have strict rules about who can join to make sure it's safe and that the results are clear. Your doctor will discuss all the requirements with you.
- Are you 18 years old or older?
- Do you experience long-term pain?
- Are you comfortable potentially taking pain medications (nefopam or oxycodone) as part of the study?
- Are you able to attend study visits as required?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
The information provided doesn't give a lot of detail about what taking part would involve. However, generally in a study like this, you might expect:
* **Visits:** You would likely need to attend several appointments at a clinic or hospital, which could involve measuring your pain and perhaps taking blood samples or other tests. * **Medication:** You would be given either nefopam or oxycodone, or possibly a placebo (a dummy pill with no medicine) at different times, according to the study plan. You would be closely monitored. * **Assessments:** You would be asked many questions about your pain, likely filling out questionnaires, and the researchers would use their new measurement tools. * **Follow-up:** There might be follow-up calls or visits after you've completed the main study activities to check on your well-being. * **Total Duration:** The total time you'd be involved in the study isn't stated, but Phase I studies can range from a few days to several weeks, often with concentrated periods of observation.
Potential risks and benefits
Locations (1)
- —Netherlands
Common questions
What kind of pain are they studying?
The study mentions 'chronic pain,' which means pain that has lasted for a long time. The specific type of chronic pain isn't detailed, but the study team can tell you if your pain condition is suitable.
Will I receive pain medicine in this study?
Yes, you will be given either nefopam or oxycodone, which are both medicines used to treat pain, or possibly a placebo (a dummy pill). You'll be closely monitored by medical staff.
Is this study testing a new pain medicine?
No, this study isn't testing brand new medicines. It's using two existing pain medicines (nefopam and oxycodone) to check how well new methods of measuring pain work.
What does 'Phase I' mean?
Phase I is an early stage of clinical research. It mainly focuses on understanding how new methods or medicines behave in people, rather than whether a new drug can treat a specific illness effectively.
Can I leave the study if I change my mind?
Yes, absolutely. You have the right to withdraw from the study at any point, for any reason, and your decision will not affect your ongoing medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.